INTRODUCTION
Chronic histiocytic intervillositis (CHIV), is a relatively uncommon and poorly understood condition, characterized by mononuclear cell infiltrate in the intervillous space which is of maternal origin. In addition there can be villous and perivillous fibrin deposition and focal villitis. As CHIV has high association with placental insufficiency, poor perinatal outcome 2, 3 and high recurrent rate in subsequent pregnancies, 4, 5 recognition of this entity is clinically important. The exact incidence of CHIV is unknown but studies conducted by Boyd et al. 4 and Doss et al. 3 have revealed incidence to be 6/10000 placentas analyzed in the second and third trimesters, and 4.4% in placentas of first trimester abortion.
The etiology of CHIV remains obscure. Presence of maternally derived mononuclear cells in the intervillous space has led to the hypothesis that an immune mechanism is involved in the pathogenesis of placental lesions. 4 Immunosuppressive and thrombolytic treatment has been proposed 4,5 as a treatment to prevent recurrent CHIV in order to ameliorate the obstetric outcome, but the efficacy is unproven.
CASE REPORT
A 22 year old primi, conceived with ovulation induction, was booked at 13 weeks of pregnancy. On investigation she was found to be hypothyroid and was started on low dose thyroxin. On subsequent visits she was also found to have mild glucose intolerance and was advised diabetic diet with metformin 500 mg per day. First and second trimester ultrasound examinations were normal and did not reveal any congenital anomalies.
At 24 weeks of pregnancy, she came with the complaints of spotting, absent fetal movements and labour pain. On admission, she was in active labour. USG examination revealed absence of fetal heart activity, confirming intrauterine death. She delivered a dead male fetus of 460 gm. Since the parents were not willing for fetal autopsy, placenta alone was sent for histopathological examination. However external examination of the fetus did not reveal any gross abnormality. ANA and APLA work up were advised on follow up.
The placenta weighed 111.0 gm (small for gestational age, <10 th percentile). There was a smaller lobe measuring 3.3x2.5x1.0 cm (succenturiate lobe)) which was connected to the larger lobe (9.5x8.0x2.0 cm) by thickened membranous tissue ( Figure 1 ). The fetal and maternal surfaces were unremarkable. The parenchyma was pale brown, spongy. The umbilical cord was white, 36.5 cm long, 1.0 cm diameter, hypocoiled with 5 twists, all to the left, had 3 vessels on the cut surface and one varix. It was inserted into the membranes, 1.0 cm from the disc margin, was furcated with one of the branches entering the accessory lobe ( Figure 2 ). The membranes were inserted marginally, pale brown and the site of rupture was 3.0 cm from the disc margin. Multiple bits were taken from the umbilical cord, membrane roll, parenchyma of smaller and larger lobes.
Microscopically the velamentous insertion of the cord was confirmed. The amnion and chorion were normal. The decidua of the membrane roll showed a focal moderate mononuclear infiltrate and multinucleate chorionic trophoblasts. Large portions of the intervillous space were filled with mononuclear cells, mainly histiocytes (Figure 3 ). The villi in these areas showed loss of trophoblastic cover and were surrounded by fibrin with nuclear debris. Immunohistochemical stain showed CD68 positivity in these mononuclear cells, thus confirming their histiocytic nature ( Figure  4 ). The syncytiotrophoblasts showed nuclear pyknosis and 'ghost nuclei'. The basal plate showed a moderate lymphohistiocytic infiltrate. A few groups of hyalinized and avascular villi were seen, but there was no significant villous inflammation. There were no viral inclusions/malarial pigment. Hence a diagnosis of chronic histiocytic intervillositis in second trimester placenta was offered. CHIV is usually found in patients with severe obstetric complications like early spontaneous abortions, late abortion, preterm deliveries, severe IUGR, intrauterine deaths and has a high rate of recurrences (60-80%) 12 in subsequent pregnancies. There are no clinical features that are specific to and predict CHIV. But a study by V. Marchaudon et al. 13 has shown elevated maternal alkaline phosphatase levels in more than 50% of their cases. Further studies needs to be conducted to validate the same as alkaline phosphatase being an isoenzyme is elevated in many other conditions. CHIV is a histopathologic diagnosis characterized by the presence of mononuclear infiltrate in intervillous spaces which are CD68 positive. 15 Intervillous inflammatory infiltrate are also noted in women with malaria, listeriosis, tularemia, coccidiomycosis, viral and rickettsial infections. In above mentioned conditions the infiltrate are either acute or mixed inflammatory cells. One should look for presence of viral inclusions, malarial pigment, bacteria and nature of inflammatory infiltrate before making a diagnosis of CHIV.
The exact etiology of histiocytic intervillositis is not known, articles about it are sparse. [1] [2] [3] [4] [5] [6] Some authors [7] [8] [9] have suggested that maternal immune reaction may be directed against the paternally derived antigens of the fetus mediated by maternal mononuclear cells, kind of graft rejection. 2, 11 This immune aggression may occur because of the failure of regulatory mechanisms that should protect the pregnancy throughout gestation 3, 4 . Overall, it has been proposed that the mechanism of CHIV may be based on an immune phenomenon of an unknown nature that causes histiocytes to flow into the intervillous space, lesions to occur in the syncytial cells, and finally syncytial coverage by fibrin deposits that progressively impair maternofetal exchanges. An association with antiphospholipid antibodies has been reported, 14 validating the hypothesis of an immunological mechanism underlying this condition.
Immuno suppressive therapy and thrombolytic treatment has been proposed 2,4,5 to prevent recurrent CHIV. Prednisolone, aspirin, heparin and progesterone were used alone or in combinations. Although various different combinations were used, the livebirth rate reported with treatment was 30% against 58.9% without treatment. 10 This difference was not statistically significant. Hence further studies need to be conducted to understand the pathophysiology and treatment choices.
CONCLUSION
It is important to recognize this rare placental pathology. Chronic histiocytic intervillositis has a big impact on the reproductive capacity of a woman, being associated with pregnancy losses, growth restriction and adverse perinatal outcome. The condition has a very high recurrence rate. Availability of an intervention to prevent a recurrence is an attractive proposition, but there are no controlled trials in CHIV. This is possibly because the lesion is rare, and also because it can only be diagnosed after delivery.
